The role of mycobacteria in the aetiology
however, has been difficult to define because of the slow growth rate and fastidious nature of this organism in vitro12 and also because of its very close similarity with Mycobacterium avium, a species ubiquitous in the environment'3 14 and therefore in the human gut. This makes accurate identification by conventional microbiological methods very difficult.
The discovery of IS900, a repeating DNA insertion element in the M paratuberculosis genome specific to that organism9 15 16 was an important step forward. Utilisation of the polymerase chain reaction (PCR) to amplify fragments of IS900 permits rapid and accurate detection of M paratuberculosis DNA from tissue without the need for laborious and time consuming culture.17 18 However, recent published reports are conflicting. Reports of positive detection of M paratuberculosis DNA from intestinal tissue of patients with Crohn's disease'9-22 were not substantiated by reports from other centres that describe negative results using PCR.23 24 Thus, a mycobacterial aetiology for Crohn's disease remains a contentious hypothesis.
Recent advances in technology combining the use of fluorochrome-labelled oligonucleotide primers for PCR, along with laser detection of the amplified fluorescent DNA products, permits more sensitive identification of positive samples. This obviates the need for laborious techniques such as Southern blotting and the handling of radioactive probes. Therefore, utilising such technology, this study was undertaken to apply these new techniques to DNA extracted from intestinal tissue so as to assess the prevalence of M paratuberculosis in the human gut from patients with Crohn's disease, ulcerative colitis, and also from noninflammatory bowel disease controls. Crohn's disease.6 7 The mycobacteria were provided in the form of solid culture on a Lowenstein-Jensen slope. The organisms were harvested and DNA extracted enzymatically by the process described above. This DNA was used as the positive control in all experiments. The concentration of M paratuberculosis DNA was assessed by fluorimetry using 0-1 pug/ml Hoechst 33258 (Polysciences, Warrington, PA) in TNE buffer, (10 control for this experiment. To the other tubes were added 50 jil aliquots of mycobacterial suspensions from stock cultures (donated by Professor J Ivanyi , London) in Kirchner's medium. The species used were M paratuber-<--. 400 bp culosis (strain 'Map'), its closest relative M avium (strain 'MaB2') and BCG-P (Pasteur). All tubes were then snap frozen in liquid nitrogen, thawed, and processed using the DNA extraction process described above. controls were added first, followed by the patient samples and specificity controls. To minimise any possibility of cross contamination, all completed tubes were capped immedi-400 bp ately after addition of their sample DNA and 400 bp moved to another part of the laboratory before the 'Linda' M paratuberculosis DNA was added to the sensitivity control tubes. The PCR was carried out on a PTC-100 Programmable Thermal Controller (MJ Research, Watertown, MA) and comprised 30 cycles of a three step program involving denaturation at 95°C for one minute, annealing at 58°C for one minutes, and extension at 72°C for two minutes. PCR controls For sensitivity controls, DNA from cultured M paratuberculosis strain 'Linda' was extracted enzymatically as above. Ten-fold serial dilutions of the extracted DNA were used to determine the sensitivity of the PCR. 'Linda' DNA was always added to the PCR positive control tubes in increasing concentrations to prevent any cross tube contamination, a potential source of misleading results for the PCR sensitivity. After initial formal identification of the limits of detection of the assay, each PCR run used M paratuberculosis DNA in three dilutions (10-6, 1O-7, and 10-8) to include the previously determined level of sensitivity and one 1 0-fold dilution either side of this to ensure no drifting of the efficiency of the reaction. Thirty cycles of PCR amplification was found to give optimum results.
The specificity of each PCR run was checked by using a panel of 10 other related mycobacterial species. These included M marinum, M gordonae, M tuberculosis, M bovis, M terrae, M reynolds, M malm, M kansasii, BCG-P, and the most closely related species M avium. These organisms were subjected to the identical DNA extraction process as the positive control 'Linda' M paratuberculosis organisms and all of the study patient tissue samples. (Fig 2) . Using the Genescan system, the limit of positive detection occurred at a dilution of 10-7 of the stock 'Linda' DNA, which corresponds to the amplification of S 10 fg of M paratuberculosis DNA, equivalent to 1-2 mycobacterial genomes. As only 1/% of the total extracted DNA was used for PCR amplification and detection, the overall limit of detection of our techniques is estimated at less than 200 bacilli per intestinal tissue specimen. Sensitivity was not compromised by freeze-thawing.
Negative controls
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DETECTION OF M PARA TUBERCULOSIS DNA IN INTESTINAL TISSUES
Despite the confirmed sensitivity, specificity, and reproducibility of the techniques, none of the intestinal samples from patients with Crohn's disease or ulcerative colitis showed amplification of M paratuberculosis DNA. Positive amplification of M paratuberculosis DNA was detected in only one of the noninflammatory bowel disease control patients. This was from a 55 year old female subject undergoing colonoscopy with a final diagnosis of irritable bowel syndrome (Fig 3) . ' 
SPIKING' AND DNA EXTRACTION EXPERIMENTS
To include inhibition of amplification by PCR, control non-inflammatory bowel disease tissue was 'spiked' with intact mycobacteria. Positive detection of a 400 base pair fluorescent amplification product was obtained from spiking with 'Map' M paratuberculosis but not from spiking with the other mycobacterial species used. The internal tissue-only control was also negative.
Direct comparison of DNA extraction techniques between out method and that described by Sanderson et al 19 showed them to be comparable in their ability to extract and amplify M paratuberculosis DNA (Fig 4) . Examination of the gel image and cross sectional electrophoretograms of individual lanes showed positive amplification of a 400 base pair product, using both methods, down to a dilution of 10-4 of the DNA extracted from the spiked Crohn's disease tissue. None of the non-spiked Crohn's disease tissue samples were positive.
Discussion
The results described here throw doubt on the hypothesis that M paratuberculosis plays a part in the aetiology of Crohn's disease. Our own early work25 using standard oligonucleotide primers, ethidium bromide agarose gels, and Southern blotting with internal radiolabelled probing produced results that were hampered by false positives. These were shown to arise because of inter-mycobacterial species cross reactions. Strenuous efforts to eradicate such cross reactions were made and our PCR assay method was refined such that we could achieve excellent and reproducible specificity. Using a fluorescent PCR method with automated analysis has also helped eliminate artefacts that can arise in gel blotting methods. Using this approach, we have shown that our IS900 PCR assay is specific for M paratuberculosis against a panel of 10 other mycobacteria including the very closely related species, M avium.26 The sensitivity of the assay was shown by the reliable and reproducible amplification and detection of 6 10 fg of M paratuberculosis DNA, corresponding to less than 200 organisms per tissue sample used in the experiment.
A potential problem in the detection of mycobacterial DNA is that mycobacterial walls are very robust, thereby potentially hampering DNA extraction. Although we initially used Johne's disease goat intestine to demonstrate effective DNA extraction, the very high density of M paratuberculosis in this tissue makes it a poor model. Therefore, in an attempt to establish a better model of the numbers of mycobacteria that might be present in human gut, we 'spiked' intestinal specimens with small aliquots of M paratuberculosis suspension before DNA extraction. The high mechanical forces required to disrupt aggregates of M paratuberculosis in suspension would have risked liberating mycobacterial DNA before enzymatic extraction and thereby created an inaccurate impression of the efficiency of our DNA extraction process. This precluded accurate qualification of actual numbers of mycobacteria detectable on 'spiking'. Nevertheless, our experiments showed amplification of DNA from even very small numbers of M paratuberculosis (strain 'Map'), with no ill effects from freezing and rethawing. Thus, we conclude that our extraction process is efficient at liberating genomic mycobacterial DNA.
As our negative results directly contradict the study reporting positive amplification of M paratuberculosis in 65% of Crohn's disease specimens, '9 Perhaps the most probable reason for the discrepancies relates to differences in technique and the possibility of artefactual positives. Laboratory contamination is a well recognised problem when using PCR27 28 and requires the most rigorous steps for its elimination. Contamination artefact may be expected to occur, however, as positives randomly distributed between the three clinical groups of Crohn's disease, ulcerative colitis and non-inflammatory bowel disease controls which does not seem to be the case in previous reports. These findings, however, could be explained if separate experimental PCR runs were performed using tissue samples from a single diagnostic group. Contamination artefacts may then appear as unexpected positives in mainly one diagnostic group. Other technical problems can occur due to excessive numbers of PCR amplification cycles and insufficient stringency using blotting methods for detection of PCR products. In fact, we attribute our own earlier preliminary positive findings25 to just such artefacts. The ease with which artefactual or false positives can be generated in some PCR detection methods underlines the fundamental importance of reliable, accurate, and reproducible PCR specificity controls.
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